Hou and colleagues could demonstrate that oncogenic BRAF V6000E in melanoma causes a large number of epigenetic alterations, including decreased expression levels of DNA-methyltransferase 1 (DNMT1) and histone methyltransferase EZH2 affecting CpG island methylation and the epigenetic landscape [185]. The gene discussed is BRAF; the disease is melanoma.